Annovis Bio (ANVS) news
Recent news
New deal: Atlas Warehouse lending $Bmark 6NCS +150 area
AInvest Wire · 11h agoCPBIO renewal of continuing connected transactions, notice of special general meeting
Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
AInvest Wire · 1d agoCPBIO renewal of continuing connected transactions, notice of special general meeting
AInvest Wire · 1d agoAnnovis announces partnership with Weave Bio, AI regulatory platform, in preparation of NDA for Buntanetap in Alzheimer’s disease
AInvest Wire · Sep 23, 2026Annovis Bio - Open-label Alzheimer's study for buntanetap to begin October 2026
Annovis Bio, Inc. (NYSE: ANVS) announced that its open-label extension (OLE) study for Alzheimer’s disease (AD) patients will begin in October 2026 . This study will allow participants who have completed the pivotal Phase 3 trial of buntanetap to continue receiving the investigational therapy. The…
AInvest Wire · Aug 25, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.